Table of Contents Author Guidelines Submit a Manuscript
Journal of Parasitology Research
Volume 2012, Article ID 134645, 10 pages
http://dx.doi.org/10.1155/2012/134645
Research Article

The Role of Vitamin D and Vitamin D Receptor in Immunity to Leishmania major Infection

1Eck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA
2Cancer Research Center, University at Albany, 1 Discovery Drive, Rensselaer, NY 12144, USA
3Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, PA 16802, USA

Received 2 May 2011; Revised 1 July 2011; Accepted 25 July 2011

Academic Editor: Marcela F. Lopes

Copyright © 2012 James P. Whitcomb et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Griffin and R. Kumar, “Effects of 1α,25(OH)2D3 and its analogs on dendritic cell function,” Journal of Cellular Biochemistry, vol. 88, no. 2, pp. 323–326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. H. P. Koeffler, T. Amatruda, and N. Ikekawa, “Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues,” Cancer Research, vol. 44, no. 12 I, pp. 5624–5628, 1984. View at Google Scholar · View at Scopus
  3. A. Berer, J. Stöckl, O. Majdic et al., “1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro,” Experimental Hematology, vol. 28, no. 5, pp. 575–583, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. M. O. Canning, K. Grotenhuis, H. de Wit, C. Ruwholf, and H. A. Drexhage, “1-α,25-dihydroxyvitamin D3 (1,25(OH)2D3) hampers the maturation of fully active immature dendritic cells from monocytes,” European Journal of Endocrinology, vol. 145, no. 3, pp. 351–357, 2001. View at Google Scholar · View at Scopus
  5. G. Penna and L. Adorini, “1α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation,” Journal of Immunology, vol. 164, no. 5, pp. 2405–2411, 2000. View at Google Scholar · View at Scopus
  6. M. T. Cantorna, C. E. Hayes, and H. F. Deluca, “1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 15, pp. 7861–7864, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. M. T. Cantorna, C. E. Hayes, and H. F. DeLuca, “1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis,” Journal of Nutrition, vol. 128, no. 1, pp. 68–72, 1998. View at Google Scholar · View at Scopus
  8. M. T. Cantorna, C. Munsick, C. Bemiss, and B. D. Mahon, “1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease,” Journal of Nutrition, vol. 130, no. 11, pp. 2648–2652, 2000. View at Google Scholar · View at Scopus
  9. D. Bruce, J. H. Ooi, S. Yu, and M. T. Cantorna, “Vitamin D and host resistance to infection? Putting the cart in front of the horse,” Experimental Biology and Medicine, vol. 235, no. 8, pp. 921–927, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. P. T. Liu, S. Stenger, D. H. Tang, and R. L. Modlin, “Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin,” Journal of Immunology, vol. 179, no. 4, pp. 2060–2063, 2007. View at Google Scholar · View at Scopus
  11. Y. C. Li, A. E. Pirro, M. Amling et al., “Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 18, pp. 9831–9835, 1997. View at Google Scholar · View at Scopus
  12. O. Dardenne, J. Prud'homme, A. Arabian, F. H. Glorieux, and R. St-Arnaud, “Targeted inactivation of the 25-hydroxyvitamin D3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets,” Endocrinology, vol. 142, no. 7, pp. 3135–3141, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. C. Li, M. Amling, A. E. Pirro et al., “Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice,” Endocrinology, vol. 139, no. 10, pp. 4391–4396, 1998. View at Google Scholar · View at Scopus
  14. O. E. Akilov, R. E. Kasuboski, C. R. Carter, and M. A. McDowell, “The role of mannose receptor during experimental leishmaniasis,” Journal of Leukocyte Biology, vol. 81, no. 5, pp. 1188–1196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. R. Carter, J. P. Whitcomb, J. A. Campbell, R. M. Mukbel, and M. A. McDowell, “Complement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c Mice,” Infection and Immunity, vol. 77, no. 12, pp. 5668–5675, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Donovan, A. S. Messmore, D. A. Scrafford, D. L. Sacks, S. Kamhawi, and M. A. McDowell, “Uninfected mosquito bites confer protection against infection with malaria parasites,” Infection and Immunity, vol. 75, no. 5, pp. 2523–2530, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Ehrchen, L. Helming, G. Varga et al., “Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major,” FASEB Journal, vol. 21, no. 12, pp. 3208–3218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Poluektova, S. Gorantla, J. Faraci, K. Birusingh, H. Dou, and H. E. Gendelman, “Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis,” Journal of Immunology, vol. 172, no. 12, pp. 7610–7617, 2004. View at Google Scholar · View at Scopus
  19. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Baldwin, A. Sakthianandeswaren, J. M. Curtis et al., “Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in the ear model of infection,” Parasite Immunology, vol. 29, no. 10, pp. 501–513, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Xie, L. Komuves, Q. C. Yu et al., “Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth,” Journal of Investigative Dermatology, vol. 118, no. 1, pp. 11–16, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Meindl, A. Rot, W. Hoetzenecker, S. Kato, H. S. Cross, and A. Elbe-Bürger, “Vitamin D receptor ablation alters skin architecture and homeostasis of dendritic epidermal T cells,” British Journal of Dermatology, vol. 152, no. 2, pp. 231–241, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. B. Zella, L. C. McCary, and H. F. DeLuca, “Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus,” Archives of Biochemistry and Biophysics, vol. 417, no. 1, pp. 77–80, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Iniesta, L. C. Gómez-Nieto, and I. Corraliza, “The inhibition of arginase by Nω-hydroxy-L-arginine controls the growth of Leishmania inside macrophages,” Journal of Experimental Medicine, vol. 193, no. 6, pp. 777–783, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Iniesta, L. C. Gómez-Nieto, I. Molano et al., “Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites,” Parasite Immunology, vol. 24, no. 3, pp. 113–118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. P. T. Liu, S. Stenger, H. Li et al., “Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response,” Science, vol. 311, no. 5768, pp. 1770–1773, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Thoma-Uszynski, S. Stenger, O. Takeuchi et al., “Induction of direct antimicrobial activity through mammalian toll-like receptors,” Science, vol. 291, no. 5508, pp. 1544–1547, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. S. E. Löfgren, L. C. Miletti, M. Steindel, E. Bachère, and M. A. Barracco, “Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals,” Experimental Parasitology, vol. 118, no. 2, pp. 197–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. Kulkarni, W. R. McMaster, E. Kamysz, W. Kamysz, D. M. Engman, and B. S. McGwire, “The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing,” Molecular Microbiology, vol. 62, no. 5, pp. 1484–1497, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Helming, J. Böse, J. Ehrchen et al., “1α,25-dihydroxyvitamin D3 is a potent suppressor of interferon γ-mediated macrophage activation,” Blood, vol. 106, no. 13, pp. 4351–4358, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. T. P. Staeva-Vieira and L. P. Freedman, “1,25-Dihydroxyvitamin D3 inhibits IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells,” Journal of Immunology, vol. 168, no. 3, pp. 1181–1189, 2002. View at Google Scholar · View at Scopus
  32. M. Cippitelli and A. Santoni, “Vitamin D3: a transcriptional modulator of the interferon-γ gene,” European Journal of Immunology, vol. 28, no. 10, pp. 3017–3030, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Reichel, H. P. Koeffler, A. Tobler, and A. W. Norman, “1α,25-Dihydroxyvitamin D3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 10, pp. 3385–3389, 1987. View at Google Scholar · View at Scopus
  34. R. M. Martin, J. L. Brady, and A. M. Lew, “The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice,” Journal of Immunological Methods, vol. 212, no. 2, pp. 187–192, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. C. M. Snapper and W. E. Paul, “Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production,” Science, vol. 236, no. 4804, pp. 944–947, 1987. View at Google Scholar · View at Scopus
  36. J. M. Lemire, D. C. Archer, L. Beck, and H. L. Spiegelberg, “Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions,” Journal of Nutrition, vol. 125, no. 6, 1995. View at Google Scholar · View at Scopus
  37. T. A. Reinhardt, J. R. Stabel, and J. P. Goff, “1,25-dihydroxyvitamin D3 enhances milk antibody titers to Escherichia coli J5 vaccine,” Journal of Dairy Science, vol. 82, no. 9, pp. 1904–1909, 1999. View at Google Scholar · View at Scopus
  38. Y. Van Der Stede, T. Verfaillie, E. Cox, F. Verdonck, and B. M. Goddeeris, “1α,25-dihydroxyvitamin D3 increases IgA serum antibody responses and IgA antibody-secreting cell numbers in the Peyer's patches of pigs after intramuscular immunization,” Clinical and Experimental Immunology, vol. 135, no. 3, pp. 380–390, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Bruce, J. P. Whitcomb, A. August, M. A. McDowell, and M. T. Cantorna, “Elevated non-specific immunity and normal Listeria clearance in young and old vitamin D receptor knockout mice,” International Immunology, vol. 21, no. 2, pp. 113–122, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. C. M. Elso, L. J. Roberts, G. K. Smyth et al., “Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway,” Genes and Immunity, vol. 5, no. 2, pp. 93–100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Gysemans, E. Van Etten, L. Overbergh et al., “Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor,” Diabetes, vol. 57, no. 1, pp. 269–275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. T. F. Meehan and H. F. DeLuca, “The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice,” Archives of Biochemistry and Biophysics, vol. 408, no. 2, pp. 200–204, 2002. View at Google Scholar
  43. K. Skorija, M. Cox, J. M. Sisk et al., “Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis,” Molecular Endocrinology, vol. 19, no. 4, pp. 855–862, 2005. View at Publisher · View at Google Scholar · View at Scopus